Alzheimer's disease

News

RFK Jr spreading 'harmful myths' on Alzheimer's research

The Alzheimer's Association has hit out at "inaccurate and dangerous fabrications" by HHS Secretary Robert F Kennedy Jr about NIH dementia research.

News

Sanofi makes Alzheimer's play with Vigil takeover

Sanofi bids to add a drug candidate for Alzheimer's disease to its neurology pipeline via the acquisition of US biotech Vigil Neuroscience.

News

FDA clears first blood test for Alzheimer's disease

The FDA has approved the first blood test for Alzheimer's disease based on a blood test – from Fujirebio – in a step forward for early diagnosis.

R&D

Shifting paradigms of clinical trial design accelerate CNS R...

Meeting the demand for clinically relevant neurodegenerative treatments requires a paradigm shift in how central nervous system (CNS) clinical trials have been designed and executed.

News

After delay, Alzheimer's drug Leqembi gets green light in EU

The EU has approved Eisai and Biogen's Leqembi for a subset of patients with early-stage Alzheimer's disease, more than two years after it was filed.

News

Alzheon Alzheimer's hopes dented by trial readout

Alzheon has been left sifting through data from a failed Alzheimer's trial for crumbs of evidence that its oral therapy may have some efficacy.

RFK Jr spreading 'harmful myths' on Alzheimer's research

Sanofi makes Alzheimer's play with Vigil takeover

FDA clears first blood test for Alzheimer's disease

Shifting paradigms of clinical trial design accelerate CNS R...

After delay, Alzheimer's drug Leqembi gets green light in EU

Alzheon Alzheimer's hopes dented by trial readout

Agios mulls early FDA filing for sickle cell therapy

Using AI-driven synthetic personas to take your insights fur...

Alzheimer's disease

Editor's Picks